Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
6.70
-1.15 (-14.65%)
At close: Aug 1, 2025, 4:00 PM
7.10
+0.40 (5.97%)
After-hours: Aug 1, 2025, 7:51 PM EDT

Biodexa Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Biodexa Pharmaceuticals.

Price Target: $0.00 (0.00%)
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

There are currently no analyst ratings available for Biodexa Pharmaceuticals.

Recommendation Trends

RatingFeb '24
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
Total0

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Ladenburg Thalmann
Ladenburg Thalmann
Strong Buy
Initiates
$200
Strong BuyInitiates$200+2,885.07%Feb 8, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.61
from -11.57
EPS Next Year
-2.94
from -2.61
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
343.00K578.00K699.00K381.00K---3.07K
Revenue Growth
-49.11%68.51%20.93%-45.49%----
EPS
----224.13-11.57-2.61-2.94-2.30
EPS Growth
--------
Forward PE
--------
No. Analysts
-----333
Financial currency is GBP. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
Highn/an/a3,157
Avgn/an/a3,067
Lown/an/a2,947

Revenue Growth

Revenue Growth202520262027
High---
Avg---
Low---

EPS Forecast

EPS202520262027
High-2.69-3.03-2.37
Avg-2.61-2.94-2.30
Low-2.51-2.82-2.21

EPS Growth

EPS Growth202520262027
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.